Predictive scores of early mortality from variceal gastrointestinal bleeding in cirrhoticpatients

##plugins.themes.academic_pro.article.sidebar##

Published Sep 19, 2017
Download
pdf
Vol. 94 No. 11 (2016): Issue Nov 2016

##plugins.themes.academic_pro.article.main##

Leila Mouelhi
Hend Ayadi
Yosra Zaimi
Oussama Daboussi
Mohamed Salem
Radhouane Debbech
Fatma Houissa
Taoufik Najjar

Abstract

Introduction: The variceal bleeding, main complication of portal hypertension during cirrhosis, is associated with high early mortality riskestimated between 15 and 20%. This highlights the necessity of predictive models that allow identifying high-risk patients raising the issue of amore aggressive therapeutic care.

Objective: To assess the performance of four scores for the prediction of cirrhotic patients’ high early mortality risk due to digestive hemorrhageand to compare them to the Child-Pugh citationsRaw score.

Methods: We collected 87 cirrhotic patients admitted to the Gastroenterology Department of Charles Nicolle Hospital for a high digestivehemorrhage by rupture of gastric or esophageal varicose veins.

Results: 56 men and 31 women were included in this study. The average value of Rockall, Glasgow Blatchford, MELD and MELD-Na scores,was respectively equal to 6.19, 10.91, and 17.6 and at 20. Early mortality was 30%. The average value of all the scores was significantly higherwith the prematurely deceased patients (p<0.001). The MELD-Na score had higher sensitivity and specificity for the prediction of prematuremortality compared to the other scores but without statistical significantly difference (Area under the ROC curve: MELD-Na=0.867, p<0.001;Child-Pugh=0.809, p<0.001; Rockall=0.777, p=0.001; Glasgow-Blatchford=0.761, p<0.001; MELD=0.838, p<0.001). The predictive value of thecut-off MELD-Na score was equal to 19 with a sensitivity of 70% and a specificity of 82%.

Conclusion: The studied four scores had a good predictive value of early mortality risk by varicose digestive hemorrhage with cirrhotic patients.

Keywords:

Cirrhosis, Bleeding, Mortality, Scores

##plugins.themes.academic_pro.article.details##

References

  1. D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003; 38:599-612.
  2. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004; 40:652-9.
  3. Reverter E, Tandon P, Augustin S, Turon F, Casu S, Bastiampillai R, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology. 2014; 146:412-9.
  4. Cerqueira RM, Andrade L, Correia MR, Fernandes CD, Manso MC. Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding. Eur J Gastroenterol Hepatol. 2012; 24:551-7.
  5. De Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015; 63(3):743-52.
  6. Bambha K, Kim WR, Pedersen R, Bida JP, Kremers WK, Kamath PS. Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis.Gut. 2008; 57: 814-20.
  7. Garcia-Pagan JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010; 362:2370-9.
  8. Rudler M, Cluzel P, Corvec TL, Benosman H, Rousseau G, Poynard T. Early-TIPS placement prevents rebleeding in high risk patients with variceal bleeding, without improving survival. Aliment Pharmacol Ther. 2014; 40(9):1074-80.
  9. Enns RA, Gagnon YM, Barkun AN, Armstrong D, Gregor JC, Fedorak RN. Validation of the Rockall scoring system for outcomes from nonvariceal upper gastrointestinal bleeding in a Canadian setting. World J Gastroenterol. 2006; 12:7779-85.
  10. Lee JY, Lee JH, Kim SJ, Choi DR, Kim KH, Kim YB, et al. Comparaison of prédictive factors related to the mortality and rebleeding caused by variceal bleeding: Child-Pugh score, MELD score and Rockall score. Taehan Kan Hakhoe Chi. 2002; 8(4):458-64.
  11. Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000; 356:1318-21.
  12. Masaoka T, Suzuki H, Hori S et al. Blatchford scoring system is a useful scoring system for detecting patients with upper gastrointestinal bleeding who do not need endoscopic intervention. J Gastroenterol Hepatol. 2007; 22:1404-8.
  13. Recio-Ramírez JM, Sánchez-Sánchez Mdel P, Peña-Ojeda JA, Fernández-Romero E, Aguilera-Peña M, Del-Campo-Molina E, et al. The predictive capacity of the Glasgow-Blatchford score for the risk stratification of upper gastrointestinal bleeding in an emergency department. Rev Esp Enferm Dig. 2015; 107(5):262-7.
  14. McLaughlin C, Vine L, Chapman L, et al. The management of low-risk primary upper gastrointestinal hemorrhage in the community: a 5-year observational study. Eur J Gastroenterol and Hepatol. 2012; 24:288-93.
  15. Hsu SC, Chen CY, Weng YM, Chen SY, Lin CC, Chen JC. Comparaison of 3 scoring systems to predict mortality from unstable upper gastrointestinal bleeding in cirrhotic patients. Am J Emerg Med. 2014; 32(5):417-20.
  16. Alessandria C, Ozdogan O, Guevara M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation. Hepatology. 2005; 41:1282-9.
  17. Terra C, Guevara M, Torre A, et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: Value of MELD score. Gastroenterology. 2005; 129:1944-53.
  18. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol. 2004; 40:897-903.
  19. Jairath V, Rehal S, Logan R, Kahan B, Hearnshaw Set al. Acute variceal haemorrhage in the United Kingdom: patient characteristics, management and outcomes in a nationwide audit. Dig Liver Dis. 2014; 46:419-26.
  20. Amitrano L, Guardascione MA, Bennato R, et al. MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol. 2005; 42:820-5.
  21. Altamirano J, Zapata L, Agustin S, Muntaner L, González-Angulo A, Ortiz AL et al. Predicting 6-week mortality after acute variceal bleeding: role of Classification and Regression Tree analysis. Ann Hepatol. 2009; 8(4):308-15.
  22. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serumsodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology. 2004; 40:802-10.
  23. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl. 2005; 11(3):336-43.
  24. Hsu CY, Lin HC, Huang YH, Su CW, Lee FY, Huo TI et al. Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis. Dig Liver Dis. 2010; 42(2):137-42.
  25. Wang J, Wang AJ, Li BM, Liu ZJ, Chen L, Wang H, et al. MELD-Na: effective in predicting rebleeding in cirrhosis after cessation of eosophageal variceal hemorrhage by endoscopic therapy. J Clin Gastroenterol. 2014; 48(10):870-7.